Murai M - Search Results

1

Elevated Akt activation and its impact on clinicopathological features of renal cell carcinoma.

Horiguchi A, Oya M, Uchida A, Marumo K, Murai M. Horiguchi A, et al. Among authors: murai m. J Urol. 2003 Feb;169(2):710-3. doi: 10.1097/01.ju.0000038952.59355.b2. J Urol. 2003. PMID: 12544348

2

Decreased acetylation of histone H3 in renal cell carcinoma: a potential target of histone deacetylase inhibitors.

Kanao K, Mikami S, Mizuno R, Shinojima T, Murai M, Oya M. Kanao K, et al. Among authors: murai m. J Urol. 2008 Sep;180(3):1131-6. doi: 10.1016/j.juro.2008.04.136. Epub 2008 Jul 18. J Urol. 2008. PMID: 18639283

3

STAT3, but not ERKs, mediates the IL-6-induced proliferation of renal cancer cells, ACHN and 769P.

Horiguchi A, Oya M, Marumo K, Murai M. Horiguchi A, et al. Among authors: murai m. Kidney Int. 2002 Mar;61(3):926-38. doi: 10.1046/j.1523-1755.2002.00206.x. Kidney Int. 2002. PMID: 11849447 Free article.

4

Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome.

Horiguchi A, Oya M, Shimada T, Uchida A, Marumo K, Murai M. Horiguchi A, et al. Among authors: murai m. J Urol. 2002 Aug;168(2):762-5. J Urol. 2002. PMID: 12131365

5

Clinical value of prostate specific antigen based parameters for the detection of prostate cancer on repeat biopsy: the usefulness of complexed prostate specific antigen adjusted for transition zone volume.

Horinaga M, Nakashima J, Ishibashi M, Oya M, Ohigashi T, Marumo K, Murai M. Horinaga M, et al. Among authors: murai m. J Urol. 2002 Sep;168(3):986-90. doi: 10.1016/S0022-5347(05)64557-0. J Urol. 2002. PMID: 12187205

6

[What is the impact of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma?].

Oya M, Murai M. Oya M, et al. Among authors: murai m. Gan To Kagaku Ryoho. 2002 Oct;29(10):1732-7. Gan To Kagaku Ryoho. 2002. PMID: 12402422 Japanese.

7

Increased activation of CCAAT/enhancer binding protein-beta correlates with the invasiveness of renal cell carcinoma.

Oya M, Horiguchi A, Mizuno R, Marumo K, Murai M. Oya M, et al. Among authors: murai m. Clin Cancer Res. 2003 Mar;9(3):1021-7. Clin Cancer Res. 2003. PMID: 12631601

8

Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma.

Oya M, Takayanagi A, Horiguchi A, Mizuno R, Ohtsubo M, Marumo K, Shimizu N, Murai M. Oya M, et al. Among authors: murai m. Carcinogenesis. 2003 Mar;24(3):377-84. doi: 10.1093/carcin/24.3.377. Carcinogenesis. 2003. PMID: 12663495

9

Renal cell carcinoma: relevance of pathology.

Oya M, Murai M. Oya M, et al. Among authors: murai m. Curr Opin Urol. 2003 Nov;13(6):445-9. doi: 10.1097/00042307-200311000-00004. Curr Opin Urol. 2003. PMID: 14560136 Review.

10

The prediction of renal function 6 years after unilateral nephrectomy using preoperative risk factors.

Ito K, Nakashima J, Hanawa Y, Oya M, Ohigashi T, Marumo K, Murai M. Ito K, et al. Among authors: murai m. J Urol. 2004 Jan;171(1):120-5. doi: 10.1097/01.ju.0000100981.11470.2f. J Urol. 2004. PMID: 14665858

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

789 results

Search Page

Filters